Your browser doesn't support javascript.
loading
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.
Ribera, Josep-Maria; García, Olga; Oriol, Albert; Gil, Cristina; Montesinos, Pau; Bernal, Teresa; González-Campos, José; Lavilla, Esperanza; Ribera, Jordi; Brunet, Salut; Martínez, María-Pilar; Tormo, Mar; Genescà, Eulàlia; Barba, Pere; Sarrà, Josep; Monteserín, María-Carmen; Soria, Beatriz; Colorado, Mercedes; Cladera, Antònia; García-Guiñón, Antoni; Calbacho, María; Serrano, Alfons; Ortín, Xavier; Pedreño, María; Amigo, Maria-Luz; Escoda, Lourdes; Feliu, Evarist.
Afiliación
  • Ribera JM; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain. Electronic address: jribera@iconcologia.net.
  • García O; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain.
  • Oriol A; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain.
  • Gil C; Hematology Department of Hospital General Universitario de Alicante, Alicante, Spain.
  • Montesinos P; Hematology Department of Hospital Universitario y Politécnico La Fe. Valencia, Spain.
  • Bernal T; Hematology Department of Hospital Central de Asturias, Oviedo, Spain.
  • González-Campos J; Hematology Department of Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Lavilla E; Hematology Department of Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Ribera J; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain.
  • Brunet S; Hematology Department of Hospital de Sant Pau, Barcelona, Spain.
  • Martínez MP; Hematology Department of Hospital Doce de Octubre, Madrid, Spain.
  • Tormo M; Hematology Department of Hospital Clínico, Valencia, Spain.
  • Genescà E; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain.
  • Barba P; Hematology Department of Hospital Vall d'Hebron, Barcelona, Spain.
  • Sarrà J; Hematology Department of Institut Català d'Oncologia-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain.
  • Monteserín MC; Hematology Department of Hospital Universitario de Getafe, Getafe, Spain.
  • Soria B; Hematology Department of Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Colorado M; Hematology Department of Hospital Marqués de Valdecilla, Santander, Spain.
  • Cladera A; Hematology Department of Hospital Son Llàtzer, Palma de Mallorca, Spain.
  • García-Guiñón A; Hematology Department of Hospital Arnau de Vilanova, Lleida, Spain.
  • Calbacho M; Hematology Department of Hospital Ramón y Cajal, Madrid, Spain.
  • Serrano A; Hematology Department of Hospital Madrid Norte Sanchinarro, Madrid, Spain.
  • Ortín X; Hematology Department of Hospital Verge de la Cinta, Tortosa, Spain.
  • Pedreño M; Hematology Department of Hospital Universitario Doctor Peset, Valencia, Spain.
  • Amigo ML; Hematology Department of Hospital General Universitario Morales Meseguer, Murcia, Spain.
  • Escoda L; Hematology Department of Institut Català d'Oncologia-Hospital Joan XXIII, Tarragona, Spain.
  • Feliu E; Hematology Department of Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Universitat Autònoma de Barcelona, Spain.
Leuk Res ; 41: 12-20, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26686475
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2016 Tipo del documento: Article